Yposkesi: [Exclusive] SK Pharmteco's French CDMO to complete construction of new plant in Q1 2023

FRANKFURT, Germany -- Yposkesi, SK Pharmteco's French contract development and manufacturing organization specialized in cell and gene therapy, is expecting to complete the construction of its new plant by the end of the first quarter next year, the CDMO's CEO said Tuesday. "After (the completion of the plant), we will qualify this manufacturing unit and we expect to get the authorization from the French authorities to operate the plant under the (Good Manufacturing Practice) b